Why is Ind-Swift Labs. falling/rising?

As of 17-Jul, Ind-Swift Laboratories Ltd is experiencing a price increase, currently at Rs 108.00, reflecting a rise of 2.95 or 2.81%. The stock has outperformed its sector by 2.39% today, reaching an intraday high of Rs 108. Despite this positive movement, the stock has shown a mixed performance over different periods, with a 1-week return of +1.93% and a 1-month return of +5.68%, while it has significantly underperformed over the past year with a decline of -24.24%. The stock's valuation appears attractive with a Price to Book Value of 0.7, and institutional investors have increased their stake by 2.59%, indicating growing confidence. However, the company has not declared results in the last six months, and its financial health is concerning, highlighted by a high Debt to EBITDA ratio and a drastic fall in net sales.
In the broader market context, the Sensex has shown a decline of -1.12% over the past week, while Ind-Swift's short-term performance has been positive, suggesting that the stock is gaining traction despite a generally weak market. The stock's year-to-date performance is down -1.55%, contrasting with the Sensex's gain of +5.27%, indicating a struggle to keep pace with the market. The significant drop in net sales and negative results over the past three quarters raise concerns about the company's long-term viability, which may overshadow the recent price increase. Overall, while there are some positive indicators, the underlying financial challenges and recent negative performance metrics suggest caution for potential investors.